ArticleCancer immunology, immunotherapy : CII2007

Low TCR avidity and lack of tumor cell recognition in CD8(+) T cells primed with the CEA-analogue CAP1-6D peptide.

Manuela Iero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.